Older Women Show Limited Understanding of Osteoporosis

This article originally appeared here.
Share this content:
Older Women Show Limited Understanding of Osteoporosis
Older Women Show Limited Understanding of Osteoporosis

FRIDAY, April 28, 2017 (HealthDay News) -- Many older women have low awareness about osteoporosis and its contribution to fracture risk and a lack of understanding about the benefits of osteoporosis pharmacotherapy, according to a study published April 19 in the Journal of the American Geriatrics Society.

Denise M. Boudreau, Ph.D., from the Group Health Research Institute in Seattle , and colleagues surveyed 985 Female Group Health Cooperative enrollees aged 55 and older with an osteoporosis-related fracture sustained from January 2013 through March 2014.

The researchers found that of 634 eligible respondents, 84 percent did not undergo osteoporosis pharmacotherapy during the six months after their fracture. Fewer than 20 percent of respondents believed that osteoporosis caused their fracture, and 52 percent did not think they were at risk of future fracture. Seventy-five percent did not think or know whether osteoporosis pharmacotherapy reduces risk of fracture, although knowledge about osteoporosis and the benefits of treatment was higher in the 16 percent of women who underwent osteoporosis pharmacotherapy after their fracture. Women also reported low levels of engagement with their health care providers regarding osteoporosis and fracture risk management.

"Information about individual's beliefs and knowledge gaps can help design targeted patient and provider education to improve treatment rates," the authors write.

All authors of the study report financial ties to the pharmaceutical industry, including Amgen, which funded the study along with UCB Pharma.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »